We are monitoring the impact of COVID-19 on MEA TAVR Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Transcatheter Aortic Valve Replacement Market Research Report – Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 321
Pages: 145

MEA TAVR Market Size (2022 to 2027)

The size of the MEA transcatheter aortic valve replacement market is expected to be worth USD 0.77 billion by 2027 from USD 0.32 billion in 2022, growing at a CAGR of 18.995% from 2022 to 2027.

The key drivers of the MEA transcatheter heart valve replacement market are the growing demand for more minor invasive procedures for high-risk patients, the increasing prevalence of mitral regurgitation and severe aortic stenosis disorders, etc., in developing countries. The older population (over 75 years old) falls into the high-risk category because the open-heart procedure is too risky for them. Cardiovascular disorders such as aortic valve defect, stenosis or mitral regurgitation, rheumatic heart disease, or infective endocarditis affect the normal heart valves, mainly degenerative. TAVR involves the implantation of transcatheter aortic valves to regenerate/ restore the blood flow capacity of the aortic valve. Cardiovascular disease is also becoming a significant health problem in Gulf Council countries, including Saudi Arabia and the United Arab Emirates. Cardiovascular disease is estimated to account for over 47% of all deaths.

Factors such as shorter recovery time, fewer hospital stays, favorable outcomes with TAVR, and advancements in technology are also driving the adoption of this procedure over open-heart surgery, which is considered the gold standard. The prevalence of significant coronary artery disease as defined by angiography in patients with aortic valve disease has ranged from 22% to 64% in previous years. Approximately 35% of all CVD deaths, ischemic heart disease, and aortic stenosis are the most causative factors. Additionally, the growing patient population seeking effective and efficient treatment with high-quality healthcare facilities is another key factor driving the adoption of this new technique in the MEA region.

However, factors such as high costs of catheter-based heart valves, device-related complications associated post-surgery, poor reimbursement policies due to less clinical trials data, product recall by manufacturers, and technique sensitivity issues are assumed to be hampering the growth the market to some extent. Additionally, the market is also challenged by the lack of advanced healthcare infrastructure and the shortage of trained healthcare professionals.

This research report on the Middle East and Africa TAVR Market has been segmented and sub-segmented into the following categories:

By Surgery Method:

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation
  • Transvaal Implantation                  

By Valve Material:

  • Nitinol
  • Stainless Steel
  • Cobalt-Chromium              

By Valve Size:

  • 14mm to 18 mm
  • 18mm to 22 mm
  • 22mm to 29mm                    

By Valve Leaflets Material:

  • Bovine Heart Tissue
  • Cow Heart Tissue
  • Other Valve Leaflets Material                       

By End Users:

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratories     

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Over the forecast period, the Middle Eastern countries are anticipated to dominate the MEA TAVR market. Middle Eastern countries such as Saudi Arabia, United Arab Emirates, Israel, Qatar, and Bahrain had a steady growth rate over the past several years and are anticipated to continue with the same trend for the years to come. Factors include the increasing geriatric population, improving healthcare infrastructure, and the increased demand for uncovered treatment procedures. In 2018, health spending as a percentage of Saudi Arabia's GDP was 6.5%. Saudi Arabia's GDP began to rise to 6.5 percent in 2018, from a low of 3% in 2008. Cardiovascular diseases are often referred to as the "silent killer" in the MEA region because mostly, the first warning sign of an underlying illness is unattended and ignored. Lack of facilities and an increased need for processing devices have led key players to invest in the Middle Eastern market.

Rapid urbanization has brought about a change in lifestyle, diet, risky behaviors, and cultural attitudes for the South African population. High blood pressure is the main complaint in the Sub-Saharan region, a significant risk factor for many CVDs. The prevalence is estimated at around 22 million in the African Region. The occurrence of cardiac disorders is expected to increase in the coming years, which positions South Africa as one of the emerging countries favoring the growth of the MEA TAVR market. This is estimated to open many growth opportunities to meet the unmet market demand during the forecast period.

KEY MARKET PLAYERS:

Some of the key participants in the MEA TAVR Market profiled in this report are Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical Inc., JenaValve Technology, Inc., Symetis SA, Direct Flow Medical, Inc., Sorin Group, Meril Life Sciences India Pvt Ltd and Braile Biomedica.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Surgery Method                                       

                                5.2.1 Introduction                           

                                5.2.2 Transfemoral Implantation                              

                                5.2.3 Transapical Implantation                   

                                5.2.4 Transaortic Implantation                   

                                5.2.5 Transcaval Implantation                    

                5.3 Valve Material                                           

                                5.3.1 Introduction                           

                                5.3.2 Nitinol                       

                                5.3.3 Stainless Steel                       

                                5.3.4 Cobalt-Chromium                

                5.4 Valve Size                                    

                                5.4.1 Introduction                           

                                5.4.2 14mm to 18 mm                    

                                5.4.3 18mm to 22 mm                    

                                5.4.4 22mm to 29mm                     

                5.5 Valve Leaflets Material                                          

                                5.5.1 Introduction                           

                                5.5.2 Bovine Heart Tissue                            

                                5.5.3 Cow Heart Tissue                 

                                5.5.4 Other Valve Leaflets Material                         

                5.6 End Users                                    

                                5.6.1 Introduction                           

                                5.6.2 Hospitals                  

                                5.6.3 Ambulatory Surgical Centres                           

                                5.6.4 Cardiac Catheterization Laboratories                           

6. Geographical Analysis                                                              

                6.5.1 Introduction                                           

                6.5.2 Middle East                                             

                6.5.2 South Africa                                            

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Edwards Lifesciences Corporation (U.S.)                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Medtronic, Inc. (Ireland)                                      

                8.3 Boston Scientific Corporation (U.S.)                                 

                8.4 Abbott Laboratories (U.S.)                                   

                8.5 St. Jude Medical Inc. (U.S.)                                  

                8.6 JenaValve Technology, Inc. (Germany)                                          

                8.7 Symetis SA (Switzerland)                                      

                8.8 Direct Flow Medical, Inc. (U.S.)                                          

                8.9 Sorin Group (Italy)                                   

                8.10 Meril Life Sciences India Pvt Ltd (India)                                        

                8.11 Braile Biomedica (Brazil)                                     

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

 

  1. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Transfemoral Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Transapical Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Transaortic Implantation Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Transcaval Implantation Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Nitinol Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Stainless Steel Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Cobalt-Chromium Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa 14mm to 18mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa 18mm to 22mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East & Africa 22mm to 29mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  15. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  16. Middle East & Africa Bovine Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  17. Middle East & Africa Cow Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  18. Middle East & Africa Other Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  19. Middle East & Africa Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  20. Middle East & Africa Hospitals Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  21. Middle East & Africa Ambulatory Surgical Centres Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  22. Middle East & Africa Cardiac Catheterization Laboratories Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  23. Middle East Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  24. Middle East Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  25. Middle East Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  26. Middle East Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  27. Middle East Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  28. Africa Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  29. Africa Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  30. Africa Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  31. Africa Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  32. Africa Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample